Skip to main content
Fig. 3 | BMC Cancer

Fig. 3

From: Improved outcome in patients following autologous stem cell transplantation for multiple myeloma in south eastern Norway 2001–2010: a retrospective, population based analysis

Fig. 3

Second and later lines of treatment. Patients ≤ 60 years of age. Percentage of patients given different treatments in the two periods. Period 1 = 01.01.2001–31.06.2005 Period 2 = 01.07.2005–31.12.2009. Sec ASCT = Salvage ASCT, VAD = Vincristin-Adriamycine-Dexamethasone, MP = Melphalan –Prednisolone, Cyclo = Cyclophosphamide, Thal = Thalidomide, Bort = Bortezomib, Len = Lenalidomide, Pom = Pomalidomide, Carfi = Carfilzomide, Benda = Bendamustine

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us